BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33077484)

  • 1. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
    Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
    Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
    Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
    Ansari IH; Longacre MJ; Stoker SW; Kendrick MA; O'Neill LM; Zitur LJ; Fernandez LA; Ntambi JM; MacDonald MJ
    Arch Biochem Biophys; 2017 Mar; 618():32-43. PubMed ID: 28193492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
    Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
    Obinata D; Takayama K; Fujiwara K; Suzuki T; Tsutsumi S; Fukuda N; Nagase H; Fujimura T; Urano T; Homma Y; Aburatani H; Takahashi S; Inoue S
    Oncogene; 2016 Dec; 35(49):6350-6358. PubMed ID: 27270436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation.
    Ma Y; Zha J; Yang X; Li Q; Zhang Q; Yin A; Beharry Z; Huang H; Huang J; Bartlett M; Ye K; Yin H; Cai H
    Oncogene; 2021 Mar; 40(10):1806-1820. PubMed ID: 33564069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characterization, Tissue Distribution Profile, and Nutritional Regulation of
    Yang Z; Zhu H; Huang X; Wang A; Xie D
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
    Radif Y; Ndiaye H; Kalantzi V; Jacobs R; Hall A; Minogue S; Waugh MG
    Mol Cell Biochem; 2018 Nov; 448(1-2):275-286. PubMed ID: 29450800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
    Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
    PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
    Castillo AF; Orlando UD; Maloberti PM; Prada JG; Dattilo MA; Solano AR; Bigi MM; Ríos Medrano MA; Torres MT; Indo S; Caroca G; Contreras HR; Marelli BE; Salinas FJ; Salvetti NR; Ortega HH; Lorenzano Menna P; Szajnman S; Gomez DE; Rodríguez JB; Podesta EJ
    Cell Mol Life Sci; 2021 Mar; 78(6):2893-2910. PubMed ID: 33068124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
    Bu SY; Mashek MT; Mashek DG
    J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.
    Van Horn CG; Caviglia JM; Li LO; Wang S; Granger DA; Coleman RA
    Biochemistry; 2005 Feb; 44(5):1635-42. PubMed ID: 15683247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
    Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
    Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.
    Migita T; Takayama KI; Urano T; Obinata D; Ikeda K; Soga T; Takahashi S; Inoue S
    Cancer Sci; 2017 Oct; 108(10):2011-2021. PubMed ID: 28771887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
    Centenera MM; Scott JS; Machiels J; Nassar ZD; Miller DC; Zinonos I; Dehairs J; Burvenich IJG; Zadra G; Chetta PM; Bango C; Evergren E; Ryan NK; Gillis JL; Mah CY; Tieu T; Hanson AR; Carelli R; Bloch K; Panagopoulos V; Waelkens E; Derua R; Williams ED; Evdokiou A; Cifuentes-Rius A; Voelcker NH; Mills IG; Tilley WD; Scott AM; Loda M; Selth LA; Swinnen JV; Butler LM
    Cancer Res; 2021 Apr; 81(7):1704-1718. PubMed ID: 33547161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
    Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
    Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
    Ye X; Zhang Y; Wang X; Li Y; Gao Y
    IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acsl, the Drosophila ortholog of intellectual-disability-related ACSL4, inhibits synaptic growth by altered lipids.
    Huang Y; Huang S; Lam SM; Liu Z; Shui G; Zhang YQ
    J Cell Sci; 2016 Nov; 129(21):4034-4045. PubMed ID: 27656110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.